RxDoctor Payments DataLook up a doctor →

Danish Jabbar, MD

Internal Medicine · Saint Louis, MONPI 1114183019

Payments from drug & device makers

$510,161in general payments, 2019–2025

Across 2,048 payments — averaging $249.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$488K
  • AbbVie$5K
  • AstraZeneca$2K
  • Novo Nordisk$1K
  • GSK$1K
  • Lilly USA, LLC$783
  • plus $12K from 54 others
$50in research payments, 2019–2025

Across 1 payment — averaging $50.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk$50

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS700$488,350
AbbVie(2 entities)285$5,198
AstraZeneca91$1,926
Novo Nordisk77$1,080
GSK80$1,007
Lilly USA, LLC51$783
Amgen52$744
Boehringer Ingelheim40$712
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC40$649
Otsuka America Pharmaceutical, Inc.33$573
Axsome Therapeutics, Inc.24$548
Pfizer61$544
Johnson & Johnson31$535
Neurocrine Biosciences, Inc.20$464
Takeda Pharmaceuticals U.S.A., Inc.32$459
Bayer24$454
Collegium Pharmaceutical, Inc.25$391
Novartis22$386
Biohaven Pharmaceuticals, Inc.55$362
Merck22$347
Astellas Pharma US Inc16$333
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$307
Biohaven Pharmaceutical Holding Company Ltd.47$276
Sunovion Pharmaceuticals Inc.18$236
Alkermes, Inc.10$219
Lundbeck LLC12$214
Amarin Pharma, Inc.15$198
Aimmune Therapeutics, Inc.9$185
Teva Pharmaceuticals USA, Inc.9$169
Supernus Pharmaceuticals, Inc.11$161
Protega Pharmaceutials Inc4$153
Scilex Pharmaceuticals Inc.9$147
Abbott8$141
Eisai Inc.9$136
Avanir Pharmaceuticals, Inc.9$121
Actelion Pharmaceuticals US, Inc.1$113
Nevro Corp.6$111
Watermark Medical, Inc.1$110
Philips North America LLC6$100
Mannkind Corporation3$87
Biodelivery Sciences International, Inc.5$74
Antares Pharma, Inc.5$71
Exact Sciences4$70
Mylan Specialty L.p.4$67
Xeris Pharmaceuticals, Inc.3$65
Azurity Pharmaceuticals, Inc.3$50
Valinor Pharma, LLC3$49
Nestle Healthcare Nutrition Inc.2$46
Corcept Therapeutics2$44
Almatica Pharma LLC3$43
Krystal Biotech Inc2$36
Neurelis, Inc.2$33
Harmony Biosciences LLC1$33
Viatris Specialty LLC2$33
Phathom Pharmaceuticals, Inc.2$30
Tactile Systems Technology Inc1$29
Boston Scientific1$27
Agios Pharmaceuticals, Inc.1$26
Radius Health, Inc.1$21
E.r. Squibb & Sons, L.L.C.1$20

How this compares

$510,161 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$224,588
Medicare patients
177
Services billed
3,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →